Article Details

VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering

Retrieved on: 2020-12-22 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering. View article details on hiswai:

Excerpt

Lead investors that participated in the offering include Acuta Capital, New Enterprise Associates (NEA), OrbiMed and Venrock Healthcare Capital ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up